Exact Mass: 520.1006

Exact Mass Matches: 520.1006

Found 23 metabolites which its exact mass value is equals to given mass value 520.1006, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Latamoxef

(6R,7R)-7-[2-carboxy-2-(4-hydroxyphenyl)acetamido]-7-methoxy-3-{[(1-methyl-1H-1,2,3,4-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C20H20N6O9S (520.1012)

Broad- spectrum beta-lactam antibiotic similar in structure to the cephalosporins except for the substitution of an oxaazabicyclo moiety for the thiaazabicyclo moiety of certain cephalosporins. It has been proposed especially for the meningitides because it passes the blood-brain barrier and for anaerobic infections. [PubChem] J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DD - Third-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

Melitric acid B

3-(3,4-dihydroxyphenyl)-2-{[(2E)-3-[(2Z)-2-[(3,4-dihydroxyphenyl)methylidene]-3-oxo-2,3-dihydro-1,4-benzodioxin-6-yl]prop-2-enoyl]oxy}propanoic acid

C27H20O11 (520.1006)

Melitric acid B is found in herbs and spices. Melitric acid B is a constituent of Melissa officinalis (lemon balm). Constituent of Melissa officinalis (lemon balm). Melitric acid B is found in tea and herbs and spices.

2',7'-Bis-(2-carboxyethyl)-6-carboxyfluorescein

2-[2,7-bis(2-carboxyethyl)-6-hydroxy-3-oxo-3H-xanthen-9-yl]benzene-1,4-dicarboxylic acid

C27H20O11 (520.1006)

lycopic acid C

C27H20O11 (520.1006)

Dendroamide B

C21H24N6O4S3 (520.1021)

Melitric acid B

3-(3,4-dihydroxyphenyl)-2-{[(2E)-3-[(2Z)-2-[(3,4-dihydroxyphenyl)methylidene]-3-oxo-2,3-dihydro-1,4-benzodioxin-6-yl]prop-2-enoyl]oxy}propanoic acid

C27H20O11 (520.1006)

Fmoc-Asn-OPfp

C25H17F5N2O5 (520.1058)

BCECF

C27H20O11 (520.1006)

7-((Carboxy(4-hydroxyphenyl)acetyl)amino)-7-methoxy-(3-((1-methyl-1H-tetrazol-5-YL)thio)methyl)-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C20H20N6O9S (520.1012)

lipol-AMP

C18H27N5O7PS2- (520.1089)

2,7-Bis-(2-carboxyethyl)-5-carboxyfluorescein

C27H20O11 (520.1006)

4,7,11-Trimethyl-18-(2-methylsulfanylethyl)-6-oxa-13,20-dithia-3,10,17,22,23,24-hexazatetracyclo[17.2.1.15,8.112,15]tetracosa-1(21),5(24),7,12(23),14,19(22)-hexaene-2,9,16-trione

C21H24N6O4S3 (520.1021)

Latamoxef

C20H20N6O9S (520.1012)

J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DD - Third-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

2,7-Bis-(2-carboxyethyl)-6-carboxyfluorescein

C27H20O11 (520.1006)

Moxalactam

C20H20N6O9S (520.1012)

A broad-spectrum oxacephem antibiotic in which the oxazine ring is substituted with a tetrazolylthiomethyl group and the azetidinone ring carries methoxy and 2-carboxy-2-(4-hydroxyphenyl)acetamido substituents.

7-(3-chloro-4-hydroxy-2-methoxy-6-methylphenyl)-2,4,9-trihydroxy-12,12-dimethyltetracene-5,6,11-trione

C28H21ClO8 (520.0925)

(2r)-3-(3,4-dihydroxyphenyl)-2-{[(2e)-3-[(3z)-3-[(3,4-dihydroxyphenyl)methylidene]-2-oxo-1,4-benzodioxin-6-yl]prop-2-enoyl]oxy}propanoic acid

C27H20O11 (520.1006)

3-(3,4-dihydroxyphenyl)-2-[(3-{3-[(3,4-dihydroxyphenyl)methylidene]-2-oxo-1,4-benzodioxin-6-yl}prop-2-enoyl)oxy]propanoic acid

C27H20O11 (520.1006)

(6r,7r)-7-{[2-carboxy-1-hydroxy-2-(4-hydroxyphenyl)ethylidene]amino}-7-methoxy-3-{[(1-methyl-1,2,3,4-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C20H20N6O9S (520.1012)

8,13,15,16-tetrahydroxy-3-methoxy-3-methyl-1,14-dioxo-6,7-dihydro-4h-2,9-dioxahexaphene-12-carboxylic acid

C27H20O11 (520.1006)

(4r,11r,18r)-4,7,11-trimethyl-18-[2-(methylsulfanyl)ethyl]-6-oxa-13,20-dithia-3,10,17,22,23,24-hexaazatetracyclo[17.2.1.1⁵,⁸.1¹²,¹⁵]tetracosa-1(21),2,5(24),7,9,12(23),14,16,19(22)-nonaene-2,9,16-triol

(4r,11r,18r)-4,7,11-trimethyl-18-[2-(methylsulfanyl)ethyl]-6-oxa-13,20-dithia-3,10,17,22,23,24-hexaazatetracyclo[17.2.1.1⁵,⁸.1¹²,¹⁵]tetracosa-1(21),2,5(24),7,9,12(23),14,16,19(22)-nonaene-2,9,16-triol

C21H24N6O4S3 (520.1021)

(2r)-3-(3,4-dihydroxyphenyl)-2-{[(2e)-3-[(2z)-2-[(3,4-dihydroxyphenyl)methylidene]-3-oxo-1,4-benzodioxin-6-yl]prop-2-enoyl]oxy}propanoic acid

C27H20O11 (520.1006)

3-(3,4-dihydroxyphenyl)-2-[(3-{2-[(3,4-dihydroxyphenyl)methylidene]-3-oxo-1,4-benzodioxin-6-yl}prop-2-enoyl)oxy]propanoic acid

C27H20O11 (520.1006)